More recently established treatments for RVO have taken a giant leap forward from laser photocoagulation since intravitreally ...

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a ...

EYLEA HD led to improved vision with extended dosing intervals, achieving non-inferior vision gains with an every 8-week dosing regimen compared to EYLEA® (aflibercept) Injection 2 mg dosed every 4 ...

The results of a phase 1b study that evaluated a potential new treatment for macular edema associated with inflammation, ...

TARRYTOWN, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA HD ® (aflibercept) ...

Eylea HD is a higher dose of an existing drug, aflibercept, that’s already used to treat wet macular degeneration and diabetic macular edema. Americans diagnosed with wet age-related macular ...

Regeneron Pharmaceuticals Inc REGN announced the first presentation of two-year (96 weeks) results from the pivotal PHOTON trial of aflibercept 8 mg with 12- and 16-week dosing regimens, compared to ...

If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are indicated ...

Researchers found a new procedure to prevent a common diabetic eye disease. 1. Many people who have diabetes also get diabetic macular edema, said Caesar Luo, MD, a retinal specialist. 2. Typical ...

New Delhi: Ophthalmologists across India are urging the central government to include advanced treatments for diabetic retinopathy under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY), the ...